TransMedics Group Inc (TMDX)
Working capital turnover
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Revenue | US$ in thousands | 441,540 | 241,623 | 93,459 | 30,262 | 25,639 |
Total current assets | US$ in thousands | 497,216 | 510,654 | 252,294 | 118,705 | 146,766 |
Total current liabilities | US$ in thousands | 59,913 | 54,934 | 23,661 | 23,238 | 11,879 |
Working capital turnover | 1.01 | 0.53 | 0.41 | 0.32 | 0.19 |
December 31, 2024 calculation
Working capital turnover = Revenue ÷ (Total current assets – Total current liabilities)
= $441,540K ÷ ($497,216K – $59,913K)
= 1.01
TransMedics Group Inc's working capital turnover has shown a positive trend over the past five years, increasing from 0.19 in 2020 to 1.01 in 2024. This indicates that the company is generating more revenue relative to its working capital investment, reflecting an improvement in efficiency in utilizing its working capital to support operations and sales. The significant increase in working capital turnover suggests that TransMedics Group Inc has been more effective in managing its current assets and liabilities to drive sales and business growth. This improved efficiency in working capital management can potentially lead to better cash flow and profitability for the company in the long term.
Peer comparison
Dec 31, 2024